Data from FDA - Curated by EPG Health - Last updated 22 December 2016
PRECAUTIONS General The lacrimal sac should be compressed by digital pressure for two to three
Information for Patients Do not touch dropper tip to any surface, as
A transient burning
Patients should be advised not to drive or engage in other
Patients may experience sensitivity to light and
Drug Interactions Cyclopentolate may interfere with the ocular anti-hypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.
It is also not known whether cyclopentolate can cause fetal
Cyclopentolate should be administered to a pregnant woman only if clearly needed.
Nursing Mothers It is not known whether this drug is excreted in human milk.
Because many drugs are excreted in human milk,
Pediatric Use Use of cyclopentolate has been associated with
Non-ocular: Use of cyclopentolate has been associated with
This drug produces reactions similar to those of other anticholinergic drugs, but the central
DOSAGE & ADMINISTRATION Adults: Instill one or two drops of
Complete recovery usually occurs in 24 hours.
Children: Instill one or two drops of
To minimize absorption, apply pressure over the nasolacrimal sac for two to three
Individuals with heavily
|Date Last Revised||11-12-2015|
|Type||HUMAN PRESCRIPTION DRUG|
|Marketing authorisation holder||Akorn, Inc.|